Lara R. Lipton

Malvern, VIC 3144, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Technology-Enabled (P)rehabilitation for Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analysis.

Technology-Enabled (P)rehabilitation for Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: December 16, 2025

Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C inhibitors.

Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C inhibitors.

Journal: Frontiers in oncology

Published: August 24, 2025

Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population.

Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population.

Journal: BMC public health

Published: February 04, 2025

Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.

Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.

Journal: British journal of cancer

Published: January 26, 2023

Botulinum toxin: a new differential diagnosis for a lytic bone lesion.

Botulinum toxin: a new differential diagnosis for a lytic bone lesion.

Journal: Journal of medical case reports

Published: July 22, 2022

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus.

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus.

Journal: Hepatology communications

Published: July 12, 2022

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 20, 2022

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Journal: Asia-Pacific journal of clinical oncology

Published: January 25, 2022

The role of depression and other psychological factors in work ability among breast cancer survivors in Australia.

The role of depression and other psychological factors in work ability among breast cancer survivors in Australia.

Journal: Psycho-oncology

Published: March 25, 2021

SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status.

SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status.

Journal: Molecular cancer therapeutics

Published: January 21, 2021

Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?

Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?

Journal: Current oncology (Toronto, Ont.)

Published: January 14, 2021

Evaluation of palliative treatments in unresectable pancreatic cancer.

Evaluation of palliative treatments in unresectable pancreatic cancer.

Journal: ANZ journal of surgery

Published: October 02, 2020

Showing 1-12 of 48

Last Updated: 09/26/2026